HIV/AIDS research remains a critical frontier in global health, focusing on everything from understanding how the virus interacts with the human immune system to developing new treatments and vaccines. This field is constantly evolving, with scientists working tirelessly to improve patient outcomes and move closer to a functional cure. Because these discoveries happen rapidly, staying updated with the latest findings is essential for both experts and the public.

At Gist.Science, we bridge the gap between complex research and clear understanding by processing every new preprint in this category directly from medRxiv. We transform these dense scientific documents into both plain-language explanations and detailed technical summaries, ensuring that the latest insights into HIV and AIDS are accessible to everyone. Below are the most recent papers we have analyzed, offering a fresh look at the ongoing fight against the virus.

📄 hiv aids

Investigating the Determinants of Cervical Cancer Disease State Among Women Living with HIV at Cancer Disease Hospital in Zambia

This study of 198 women living with HIV at Zambia's Cancer Disease Hospital reveals that while effective antiretroviral therapy has decoupled HIV disease status from cervical cancer stage, younger women and peri-urban residents remain at highest risk for late-stage diagnosis, highlighting a critical need for improved screening coverage.

Tembo, S., Mapiki, C., Kombe, M. M., Michelo, C.2026-08-11
📄 hiv aids

Acceptability of receiving HIV and sexual and reproductive health services at hair salons among university students in Zambia: a cross-sectional survey

A cross-sectional survey of 846 female university students in Zambia found that while acceptability of receiving HIV and sexual and reproductive health services at hair salons varies by specific service, hair salons represent a promising, demedicalized community setting for reaching at-risk young women, particularly as higher perceived HIV risk correlates with greater service acceptability.

Chiaborelli, M., Nayame, L., Hamoonga, T. E., Mweemba, O., Kopeka, M., Hampanda, K., Amstutz, A.2026-08-10
📄 hiv aids

Bayesian Spatiotemporal Small-Area Estimation of HIV Testing Uptake in Ghana, 2008-2022: Integrating Machine-Learning-Derived Geospatial Covariates with District-Level BYM2-RW1 Modelling of the Ghana Demographic and Health Surveys

This study utilized a Bayesian spatiotemporal hierarchical model integrating machine-learning-derived geospatial covariates with Ghana Demographic and Health Survey data from 2008 to 2022 to generate calibrated district-level estimates of HIV testing uptake, revealing a persistent north-to-south gradient and identifying specific clusters for targeted intervention that remain unexplained by accessibility and urbanicity alone.

Iddrisu, O. A.-F., Abukari, H. S., Siddiq, A. I.2026-08-03
📄 hiv aids

Pre-migratory, Migratory and Post-migratory Factors Associated with Risky Sexual Behaviour among Women Informal Cross-Border Traders at the COMESA Market, Lusaka, Zambia

This study of 499 women informal cross-border traders in Lusaka, Zambia, reveals that risky sexual behavior is significantly influenced by a continuum of pre-migratory, migratory, and post-migratory factors, including reliance on family capital, specific border routes like Katima Mulilo, and accommodation conditions, underscoring the need for targeted interventions focusing on financial independence and safe living environments.

Mwale, S., Lemba, M., Phiri, M.2026-07-25
📄 hiv aids

Time to PrEP Disengagement and Associated Factors Among Adolescents and Young Adults from Key and Priority Populations in Uganda. A survival Analysis

This retrospective survival analysis of 3,553 adolescents and young adults in eastern Uganda reveals that PrEP disengagement occurs rapidly within the first year, with retention significantly influenced by relational factors like partner HIV status and marital status, as well as service delivery modality and specific vulnerabilities such as STIs and gender-based violence.

Mwima, S., Walwo, S.2026-07-24
📄 hiv aids

Mortality and associated factors among people living with HIV newly initiated into care at Bamenda Regional Hospital: A Retrospective Cohort Study

This retrospective cohort study of 331 newly initiated HIV patients at Bamenda Regional Hospital found a 7.6% three-year mortality rate significantly associated with male sex, opportunistic diseases, comorbidities, abnormal liver enzymes, and advanced WHO clinical stage, highlighting the need for early diagnosis and integrated management of these risk factors.

Ajamah, F., Zefack, J. T., Mengnjo, L. T., Yongwa, O., Ashu, M. A., Nkengfua, S. F., Mbinyui, H., Ketchaji, A.2026-07-20✓ Author reviewed ⓘ
📄 hiv aids

Development and pilot testing of an empowerment-based intervention for adolescents and young adults living with HIV transitioning to adult HIV care in Uganda

This study developed and pilot-tested the Empowerment and Personal Transformation (EPT) intervention for adolescents and young adults living with HIV in Uganda, finding it to be a highly feasible and acceptable approach that effectively addresses the psychosocial and behavioral challenges associated with transitioning to adult HIV care.

Ashaba, S., Favina, A., Baguma, C., Tushemereirwe, P., Nansera, D., Comfort, A., Perkins, J. M., Maling, S., Zanoni, B. (…)2026-06-29
📄 hiv aids

''Circumstantial Determinants'': An Efficient Approach to Reaching People in Need of HIV Prevention?

This study proposes and validates a "Circumstantial Determinants" approach in Zimbabwe, demonstrating that targeting HIV prevention services based on specific social circumstances and settings rather than self-reported risk behaviors can significantly improve the reach and efficiency of identifying priority populations for intervention.

Bagnay, S. H., Gregson, S., Skovdal, M., Maswera, R., Moorhouse, L. R., Ncube, G., Tsenesa, B., Mandizvidza, P., Pickles (…)2026-06-22
📄 hiv aids

Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trial

In the RIO trial, participants receiving long-acting broadly neutralizing antibodies (3BNC117-LS and 10-1074-LS) experienced enhanced HIV-1 control and a significant reduction in intact proviral reservoirs compared to placebo, with delayed viral rebound correlating to the reservoir's sensitivity to both infused and autologous antibodies.

Fumagalli, M., Kaczynska, A., Allombert, M., Ribeiro, A. L., da Silva, M. O., Hernandez, B. J., Lavine, C., Espinosa, S. (…)2026-06-05